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Background. Fat affects gastric emptying (GE). 5-Hydroxythryptophan (5-HTP) is involved in central and peripheral satiety
mechanisms. Influence of 5-HTP in addition to saturated or monounsaturated fatty acids (FA) on GE and hormone release was
investigated. Subjects/Methods. 24 healthy individuals (12f : 12m, 22–29 years, BMI 19–25.7 kg/m2) were tested on 4 days with
either 5-HTP + short-chain saturated FA (butter), placebo + butter, 5-HTP + monounsaturated FA (olive oil), or placebo + olive
oil in double-blinded randomized order. Two hours after FA/5-HTP or placebo intake, a 13C octanoid acid test was conducted.
Cortisol, serotonin, cholecystokinin (CCK), and ghrelin were measured, as were mood and GE. Results. GE was delayed with
butter and was normal with olive (𝑃 < 0.05) but not affected by 5-HTP. 5-HTP supplementation did not affect serotonin levels.
Food intake increased plasma CCK (𝐹 = 6.136; 𝑃 < 0.05) irrespective of the FA. Ghrelin levels significantly decreased with
oil/5-HTP (𝐹 = 9.166; 𝑃 < 0.001). The diurnal cortisol profile was unaffected by FA or 5-HTP, as were ratings of mood, hunger,
and stool urgency. Conclusion. Diverse FAs have different effects on GE and secretion of orexigenic and anorexigenic hormones.
Supplementation of 5-HTP had no effect on plasma serotonin and central functions. Further studies are needed to explain the
complex interplay.
1. Introduction
The worldwide prevalence of overweight and obesity is
increasing epidemically [1]. The reasons are mainly seen
in the growing trend of physical inactivity, coupled with a
high caloric intake of easily available and highly palatable
energy-rich foods, being generally sweet and/or fatty [2].The
altered eating behaviour of overweight people is frequently
associated with delayed gastric emptying and other motility
changes of the gut [3]. In addition, food components such
as fatty acids (FA), proteins, and carbohydrates influence
gastrointestinal conditions and hormone release differently.
In obese people, a protein-rich diet resulted in delayed gastric
emptying, whereas a high carbohydrate meal accelerated
gastric emptying [4]. In general, FA chain length and the
ratio between saturated and unsaturated FA have a regulatory
effect on gastric emptying, on appetite, and on hormone
release [5], for example, the anorexigenic-acting cholecys-
tokinin (CCK) [5] and the orexigenic hormone ghrelin [6].
Another factor discussed in connectionwith gastric emp-
tying, eating behaviour, and satiety is the amino acid tryp-
tophan, the precursor of serotonin [7, 8]. In the serotonergic
pathway, tryptophan is converted to 5-hydroxytryptophan (5-
HTP) by the rate limiting enzyme tryptophan hydroxylase.
A distinction is made between two isoforms, tryptophan
hydroxylase-1, which is formed in several tissues of the body,
and tryptophan hydroxylase-2, which is only found in the
brain.The enzyme aromatic L-amino acid decarboxylase syn-
thesizes serotonin (5-HT). Máté et al. [9] recently analyzed
gene expression during the postnatal development of the
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myenteric plexus in transgenic mice and found that some
neurons simultaneously expressed both CCK and 5-HTP.The
authors suggest a possible regulatory role of these special
neurons in feeding due to the coexistence of CCK and 5-HTP.
Two established methods exist to investigate the role
of tryptophan originating from food on serotonin and its
role in regulating central and peripheral functions. Acute
tryptophan depletion (ATD) is a temporary reduction of
tryptophan and 5-hydroxyindoleacetic acid in plasma and
in serotonin availability in the central nervous system [10].
This is achieved by the administration of an amino acid drink
that does not contain tryptophan; consequently the neuronal
production of serotonin is reduced for hours. This was found
to delay gastric emptying as compared to the balanced drink
in healthy volunteers [7]. ATD induces typical intestinal
symptoms in patients with irritable bowel syndrome (IBS)
[11] and also central symptoms in depressed patients [12] and
migraine sufferers [13].
The second technique employs the food supplementation
of tryptophan or 5-HTP (ATS) in different amounts (500mg
to 5 g), resulting in increased plasma tryptophan levels and
availability of serotonin in the central nervous system. In
1989, a study with obese women found that 8mg/kg 5-HTP
daily resulted in a threefold weight loss as compared to a
placebo control group [8]. However, the reported effects are
less consistent across studies. A delay in gastric emptying
among healthy humans following the administration of L-
tryptophan was also noted for ATS [14].
Both ATD and ATS exhibit central as well as peripheral
(intestinal) effects, raising the issue ofwhether andhownutri-
tional tryptophan is distributed to the brain and the enteric
nervous system in humans. In 1976, Shindo and Miyakoshi
[15] analyzed the distribution of orally administered 14C-
labeled 5-HTP in rats by autoradiographic studies. After a
fast intestinal resorption, they found L-5-HTP in the mucosa
of the stomach and the gut, in the kidneys, in the pancreas,
in the liver, in the spleen, in the skin, and in the central
nervous system. Another study by Geeraerts et al. [16] found
a significant reduction in serotonin concentrations in the
enterochromaffin cells of the human intestine following ATD
in comparison to placebo; however, they did not measure
central serotonin concentrations.
The aim of this pilot study was to clarify which of the
two systems, the central or the enteric nervous system,
expresses the higher priority and thus stronger responses
under ATS conditions. Due to the faster resorption of 5-
HTP in the intestines [15] and the fact that 5-HTP can
pass the blood brain barrier without the presence of a
transport molecule [17], we administered 5-HTP instead of
tryptophan. Tryptophan has to share its transport molecule
with other competitive amino acids leading to an inhibited
uptake. This was combined with the question whether the
fatty acid chain length and the ratio between saturated and
unsaturated FAs differentially affect gastric emptying, the
circulating levels of anorexigenic and orexigenic hormones,
stress hormone release, and whether serotonin is involved in
this regulation.
2. Methods
2.1. Participants and Study Design. Twenty-four healthy par-
ticipants (12 females, 24.6 ± 1.9 (22–29) years, body mass
index (BMI) 22.2± 1.6 kg/m2) were recruited. All participants
gave written informed consent before participating in the
study. This randomized, double-blinded placebo-controlled,
cross-over study was approved by the Ethical Board of the
University of Tuebingen Medical Faculty. No legal registra-
tion of the study was required because all used supplements
originated from nutritional sources and are not regarded as
drugs according to German and European standards.
2.2. Protocol. Each participant was investigated on four sep-
arate days, with at least three days between two consecutive
tests. The sequence of all 4 experimental groups (5-HTP +
butter; 5-HTP + olive oil; placebo + butter; placebo + olive
oil) was randomized and completely balanced across subjects
and groups.
On all four occasions, participants were requested to
arrive at the laboratory at 07.45 h, after a 12-hour fast. After
taking the first blood sample, participants received two gela-
tine capsules filled with either 500mg 5-hydroxytryptophan
(5-HTP) or sugar in the placebo group, respectively. The
lowest 5-HTP concentration that was normally used in other
studies (range from 500mg to 5 g) was administered in this
pilot study, with the idea for a further study testing different
concentrations. The participants were asked to stay in the
room and refrain from smoking and eating, and physical
activity was prohibited.
Two hours later (10.00 a.m.), they received the regular
test meal for the 13C octanoid acid breath test. It was admin-
istered two hours later than the 5-HTP/placebo capsules,
because the interesting time point of gastric emptying is 2 h
postprandiumwhereas acute tryptophan depletion occurs 4 h
after administration. The test meal consisted of two slices
of toast (50 g), one fried egg, 100 𝜇L 13C octanoid acid, and
80mL of orange juice.The juice was enriched with either 40 g
of tepid olive oil (long-chain, single-saturated FA) or melted
butter (short-chain saturated FA). Furthermore, the FA group
was masked in this way.The meals therefore contained about
12.5 g protein and about 32.2 g carbohydrates. Due to the
different physical and caloric density of olive oil and butter,
the meal with butter included 41.1 g of fat (whole meal:
550 kcal) whereas the meal with olive oil contained 47.6 g fat
(whole meal: 609 kcal).
For the next 4 hours, breath samples were taken every 15
minutes for gastric emptying assessment. Saliva samples were
taken every hour starting at 9.45 h to assess cortisol release.
Blood samples were drawn at 8.00 h (t1), 10.30 h (t2), 12.00 h
(t3), and 13.30 h (t4) for measurement of plasma levels of
CCK, ghrelin, and serotonin.
Mood was rated on the Profile of Moods States (POMS;
adapted German version: ASTS) [18]. The POMS is a 19-
item validated test that assesses subjective well-being and has
been shown to be sensitive to short-term acutemood changes
on five dimensions (sadness, hopelessness, tiredness, positive
mood, and anger) and on global negative and positive mood
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scales [19]. Ratings were taken at 08.15 h, 10.15 h, 11.00 h,
12.00 h, 13.00 h, 14.00 h, and 18.00 h.
After leaving the laboratory, participants were instructed
to keep a diary for 24 hours about complications (e.g., nausea,
diarrhoea, and changes in taste sensation) and changes in
hunger and stool consistency and urgency.
2.3. Gastric Emptying. Gastric emptying was measured using
the 13C octanoid acid breath test technique. It provides
similar results compared to the gold standard measurement
method for gastric emptying scintigraphy [20]. After passing
through the stomach, the stable carbon isotope of the 13C
octanoid acid is rapidly absorbed in the duodenum. It is then
oxidized to 13CO
2
in the liver. The 13CO
2
is immediately
exhaled via lungs and can be analyzed in exhaled air col-
lected in special bags. Nondispersive infrared spectroscopy
(FANci2, Fischer Analysen Instrumente GmbH, Leipzig,
Germany) was used for measuring the ratio of 13C-to-12C
in the CO
2
in the breath. The half-life (HLF) of gastric
emptying was calculated using an approved algorithm [20].
Reference values for the normal rage of HLF were taken
from literature [20] and from manufacturer data (according
to Wagner Alalysen Thechnik GmbH, 13C breath tests in
action).
2.4. Blood Samples and Immunoassays. The EDTA blood
sample was immediately centrifuged after collection. Plasma
supernatant was then transferred into 1.5mL tubes and
frozen at −80∘C for later analysis. The concentrations of
serotonin (5-hydroxytryptamine, 5-HT), CCK, and ghrelin
were assessed in the plasma supernatants by immunoas-
says. Serotonin was determined by commercial enzyme
immunoassay (ELISA) kits according to the manufacturer’s
instructions (IBL, Hamburg, Germany). CCK was analyzed
by radioimmunoassay (RIA) established at the gastroenterol-
ogy laboratory of the University Hospital, Munich, Germany
[21]. It detects all biological active, sulphatedmolecular forms
of CCK with <1% cross-reactivity to sulphated gastrin. The
respective coefficients of intra-assay variation were 5.6% and
11.1% and those of interassay variation 12.3% and 13.1%.
The same laboratory measured ghrelin using a commercial
RIA (Phoenix Pharmaceuticals, Belmont, CA) according to
the manufacturer’s instructions, using 125I-labeled bioactive
ghrelin as tracer molecule and polyclonal antibody raised
in rabbits against full-length octanoylated human ghrelin
(intra-assay coefficient of variation 4%). No cross-reactivity
with human secretin, human vasoactive intestinal peptide,
human galanin, human GHRH, NYP, or other relevant
molecules has been reported [22].
2.5. Saliva Samples and Cortisol Analysis. Saliva samples
were collected in special tubes (Salivette, Sarstedt AG & Co,
Nümbrecht, Germany) to assess salivary cortisol concentra-
tions, which exhibit a good correlation with the unbound
cortisol concentration in serum and thuswith the biologically
active form [23]. A cotton roll was chewed for about one
minute and then stored in the Salivette tube. After centrifuga-
tion, samples were frozen and later analyzed for the cortisol


























Figure 1: Half-life of gastric emptying. The influence of 5-
hydroxytryptophan (5-HTP) and fatty acid ingestion on the half-
life (HLF) of gastric emptying. Participants received a capsule with
either 5-HTP or placebo (Pl). Additionally they ingested a standard
meal supplemented with 100 𝜇L 13C octanoid acid and either butter
(Bu) or olive oil (Oil). A breath test sample was taken every 15min
over the next 4 hours. The data is presented as means ± SE of the
HLF of gastric emptying. Statistics: HLF; no statistical significance
within the 4 conditions. There was a significant difference between
the summarized butter and olive data, 𝑃 < 0.05.
concentration using a fluorescence immunoassay [24] at the
Department of Biological Psychology, Technical University
Dresden, Germany.
3. Statistics
Kolmogorov-Smirnov tests were used to test for normal dis-
tribution. Data were compared between conditions (5-HTP,
placebo), fatty acid condition (olive oil, butter) and time
points (t1, t2, t3, and t4 for blood parameters) by the 2 × 2 × 4
repeated measure ANOVA, while individual measures were
analyzed by 2 × 2 ANOVA. Wilcoxon-single-ranks test was
used for the analysis of HLF data between both conditions.
Probability values of 𝑃 < 0.05 were considered statistically
significant. All analyses were performed by SPSS version 13.
All data are presented as means ± SE.
4. Results
4.1. Gastric Emptying. When values of the oil group and
the butter group were summarized regardless of the 5-HTP
group, the mean HLF value in the olive oil group was in the
normal rage of literature reference values, with 127.3± 43min.
TheHLFmean value in the butter group differed significantly
from the olive oil group HLF value (𝑃 < 0.05) and was, with
153.9 ± 72min and compared to literature values, delayed.
As the normal range depends on the administered food
composition, the measured values of the placebo conditions
in our study have to be regarded as reference values. Mean
HLF was 152 ± 68min for 5-HTP + butter, 151 ± 77min
for placebo + butter, 132 ± 45min for 5-HTP + oil, and
126 ± 42min for placebo + oil (Figure 1). There were no
statistically significant differences between the groups and
also no influence of 5-HTP supplementation.
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Figure 2: Serotonin plasma levels. The influence of 5-hydrox-
ytryptophan (5-HTP) and fatty acid ingestion on serotonin plasma
concentrations. Participants received a capsule with either 5-HTP or
placebo (Pl). They also ingested a standard breakfast supplemented
with 100 𝜇L 13Coctanoid acid and either butter (Bu) or olive oil (Oil).
Plasma samples were taken during fasting (t1) and after 5-HTP or
placebo intake after 2.5 hrs (t2), 4 hrs (t3), and 5.5 hrs (t4).The actual
plasma concentrations of serotonin protein are presented as means
± SE. Statistics: serotonin; no statistical significance.
4.2. Serotonin, CCK, and Ghrelin Plasma Levels. Serotonin
concentrations remained unchanged after 5-HTP (or
placebo) supplementation for each of the fatty acid groups
(Figure 2).
As expected, CCK plasma levels increased after the
meal and reached a maximum at 120min (t3) after meal
administration (F = 6.136; 𝑃 < 0.05; Figure 3(a)). The ele-
vated CCK values at 120min (t3) and 210min (t4) after meal
administration did not reach significance due to high stan-
dard deviations. In contrast, plasma ghrelin concentrations
decreased after the meal, reaching their minimum at 120min
(t3) and rising again at 210min (t4) postprandially (F =
10,038; 𝑃 < 0.001). Adjusting the individual ghrelin data to
the respective fasting values at t1 (Figure 3(b)) resulted in a
significant interaction of 5-HTP supplementation and fatty
acids. The plasma ghrelin levels were significantly reduced in
the 5-HTP + olive oil group (F = 9.166; 𝑃 < 0.001) but not
under 5-HTP + butter.
4.3. Cortisol Saliva Levels. As expected, a significant daytime-
related decrease in the cortisol levels was measured (F =
53.814; 𝑃 < 0.001) (Figure 4). Neither the supplementation
of 5-HTP nor administration of fatty acids had any influence
on the cortisol levels.
4.4. Satiety, Stool, and Mood Rating. Neither the adminis-
tration of different fatty acids nor the supplementation of
5-HTP had any influence on the POMS scales for sadness,
hopelessness, tiredness, positive mood, and anger (data not
shown). It also did not affect hunger (Figure 5) and stool
ratings (data not shown) within the first 24 hours after the
test.
5. Discussion
Our study gained new insight into the influence of different
fatty acid conditions (short-chain saturated or monounsatu-
rated) in combination with 5-HTP on gastric emptying and
hormone release. We found (1) that the administration of
40 g butter resulted in a delayed gastric emptying; however,
the HLF in the olive oil group was in the normal range.
Supplementation of 5-HTP showed no effect. (2) Neither the
administration of FA nor 5-HTP supplementation influenced
serotonin plasma levels. (3) Following the administration of
the fatty meals, CCK plasma levels increased over time and
caused a decrease in the ghrelin plasma levels. This decrease
was significantly different in the 5-HTP + olive oil group. (4)
The diurnal profile of cortisol in saliva was unaffected by the
administration of FA and 5-HTP supplementation, as were
mood, hunger, and stool ratings.
The aim of the present study was to clarify the priority
ratio of serotonin in the two different nervous systems,
CNS (changes in mood) and ENS (HLF), under different
conditions. In our case, no changes in mood/hunger/stool
could be observed, but gastric emptying was delayed in the
butter group and at the end of the normal range in the olive
oil group. This may be best explained by the caloric content
and the composition of our test meal. It contained 40 g fat
and had a caloric content of 550 to 608 kcal. Hunt and Stubbs
showed that the HLF depends on the caloric content (longer
after 550 kcal compared to 250 kcal). Additionally, a high fat
content leads to a delay in gastric emptying [25] and causes,
among other effects, the release of CCK which is responsible
for an inhibition of gastric emptying [26].
5.1. Gastric Emptying and SerotoninMetabolites. In this study,
we did not find any influence of supplemented 5-HTP, the
precursor of serotonin, on the HLF. To our knowledge, there
are no studies analyzing the effect of the oral administration
of 5-HTP in humans in connection with gastric emptying.
In dogs, 5-HTP increased gastric motility but had no influ-
ence on gastric emptying [27]. In humans, the intravenous
administration of 5-HTP resulted in an inhibition of gas-
tric motility, whereas gastric emptying was not investigated
[28]. Interestingly, the results after the administration of L-
tryptophan are contrary to the findings with 5-HTP. Van
Nieuwenhoven et al. found a significantly delayed gastric
emptying in eight of ten healthy women during an ATD
condition compared to placebo (HLF ATD: 137.2min; HLF
placebo: 98.5min). They hypothesized that alterations in
gastrointestinal motility might be manipulated by nutritional
factors in healthy subjects [7].
With olive oil/5-HTP and /placebo, gastric emptying time
was near the normal range suggesting thatmore 5-HTP could
be absorbed faster. Nonetheless, the amount of absorbed 5-
HTP could not change serotonin plasma levels. However, it
is imaginable that there are changes at the level of duodenal
serotonin production. About 90 percent of body’s serotonin
is accumulated in the gut [29], 95 percent of which is stored
in the secretory granules of enterochromaffin cells [30].
Keszthelyi et al. conducted a study in which they analyzed
the effect of oral administered 5-HTP (100mg) on intestinal
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Figure 3: Cholecystokinin and ghrelin. The influence of 5-hydroxytryptophan (5-HTP) and fatty acid ingestion on cholecystokinin (CCK
(a)) and ghrelin (b) plasma concentrations. Participants received a capsule with either 5-HTP or placebo (Pl). They also ingested a standard
breakfast supplemented with 100 𝜇L 13C octanoid acid and either butter (Bu) or olive oil (Oil). Plasma samples were taken during fasting (t1)
and after 5-HTP or placebo intake after 2.5 hrs (t2), 4 hrs (t3), and 5.5 hrs (t4). In (a) and (b) the actual plasma concentrations of CCK and
ghrelin protein are presented as means ± SE. Statistics: CCK; time: F = 6.136; 𝑃 < 0.05. Ghrelin; fatty acid∗5-HTP/Pl: F = 9.166; 𝑃 < 0.001.
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Figure 4: Cortisol. The influence of 5-hydroxytryptophan (5-HTP)
and fatty acid ingestion on the circadian profile of saliva cortisol
concentrations. Participants received a capsule with either 5-HTP or
placebo (Pl). They also ingested a standard breakfast supplemented
with 100 𝜇L 13Coctanoid acid and either butter (Bu) or olive oil (Oil).
Saliva samples were taken during fasting (t1 at 8:00) and after 5-
HTP or placebo intake after 1:45 hrs (t2), 2:45 hrs (t3), 3:45 hrs (t4),
and 4:45 hrs (t5).The actual saliva concentrations of cortisol protein
are presented as means ± SE. Statistics: cortisol; time: (F = 53.814;
𝑃 < 0.001).
barrier function and mucosal 5-HTmetabolism in 15 healthy
volunteers. They found that 5-HTP levels in tissue samples
of the duodenal mucosa were significantly increased, but 5-
HT levels were unaffected [31]. These changed 5-HTP levels
may be responsible for the delay in gastric emptying andmay
regulate the secretion of gastric hormones.
5.2. Influence of Serotonin Metabolites and Fatty Acids on
Hormone Release [32]. In our present study, we administered
butter and olive oil. According to Baltes, olive oil mainly
consists of fatty acids with more than 16 carbon atoms,
while butter contains fatty acids with less carbon atoms [32].




















Figure 5: Hunger rating. The influence of 5-hydroxytryptophan
(5-HTP) and fatty acid ingestion on the sensation of hunger.
Participants received a capsule with either 5-HTP or placebo (Pl).
They also ingested a standard breakfast supplemented with 100 𝜇L
13C octanoid acid and either butter (Bu) or olive oil (Oil). Over the
next 24 hours, the sensation of hunger was recorded using a scale
ranging between 0 (no sensation of hunger) and 10 (strong sensation
of hunger). The data are presented as means ± SE. Statistics: no
statistical significance.
Assuming that the preabsorptive effects of the fatty acid
composition of the different fats result in various diverse
changes in hormone secretion, this can be an explanation
for the significant reduction in the plasma ghrelin levels
in our olive oil group. In our present case, however, this
effect only occurs in the 5-HTP plus olive oil group and
is nearly completely absent in the placebo/olive oil group.
Therefore, in the present study, 5-HTP supplementation also
has to play a distinct role regarding the regulation of hormone
concentrations. Zhang et al. explored the influence of oral
infusion of tryptophan in comparison to 5-HTP and saline
on ghrelin expression, food intake, and weight gain among
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weanling pigs. It was revealed that plasma ghrelin levels
were highest after tryptophan administration. After the 5-
HTP infusion, food intake was lower than after taking saline;
however, tryptophan induced an increase in food intake.
It was concluded that tryptophan administration increases
ghrelin expression in the gastric fundus and the plasma
ghrelin levels [33]. In another animal study, Tena-Sempere
and colleagues showed that ghrelin has an inhibiting effect
on prolactin release, independent of 5-HTP. They concluded
that ghrelin inhibits prolactin secretion without the influence
of the nitric oxide, dopamine, and serotonin systems [34].
In our study we not only found—as expected—a decrease
in plasma ghrelin after a meal and 5-HTP/placebo admin-
istration, but also found an interaction of the 5-HTP sup-
plementation and FAs. In all four groups, ghrelin levels
decreased after consuming the meal due to the suppressing
effect on ghrelin secretion by the ingestion of carbohydrates
and fat [35]. However, a maximum decrease in ghrelin was
observed in the 5-HTP + olive oil group two hours after the
administration of the test meal. Therefore, we propose that
the chain length of fatty acids in a meal differently influences
ghrelin secretion.
Similarly, Feltrin et al. analyzed the influence of various
fatty acid chain lengths on different gut hormone levels.They
revealed that dodecanoic acid (C12) and decanoic acid (C10)
both stimulatedCCK secretion, but ghrelin plasma levels only
significantly decreased in theC12-acid group.They concluded
that the effects of fatty acids on ghrelin have to be dependent
on their chain lengths and on the different pathways of
absorption. The authors suggested that preabsorptive factors
might be responsible for the different ghrelin levels after the
ingestion of C12 and C10 fatty acids [6]. Furthermore, the
release of CCK increased in the presence of fat which may
be responsible for the inhibition of gastric emptying [36].
In addition, it has been shown that CCK and serotonin are
linked in the control of satiety and that tryptophan treatment
leads to a significant decrease in CCK concentrations in the
hypothalamus of rats [37].
5.3. Limitations of the Study. Weneed to acknowledge several
limitations of this pilot study. Firstly, a more differentiated
rating of hunger would have allowed assessment of hunger
and satiety in parallel with mood ratings and other measures
of central nervous system (CNS) functions in parallel with
mood. Kunisato et al. performed a resting-state fMRI study
with 21 healthy men in which they showed that changes
in some subscores of the POMS correlated with changes in
orbitofrontal cortex (OFC) activity of the brain under ATD.
Less activity of the OFC was associated with an increase
of depressive mood during the depletion situation [38]. To
the best of our knowledge, there are no imaging studies
which investigate the influence of orally administered 5-HTP
supplementation on the brain.
Whilst we did not assess blood 5-HTP levels, routine
assessment of tryptophan and its metabolites in tissue sam-
ples from the gut appears to be too invasive for a pilot study
but may be considered in subsequent investigations.
6. Conclusion
In summary, different fatty acids appear to have different
effects on gastric emptying and the release of orexigenic
(ghrelin) and anorexigenic (CCK) hormones, and 5-HTP
supplementation has no effects on core CNS functions,
serotonin plasma levels, and cortisol salvia.This can be inter-
preted in two different ways. Either the observed peripheral
effects on the intestine, such as changes in hormone levels, are
directly influenced by the increased amount of tryptophan
and the various fatty acids, or serotonin production in the
enterochromaffincells is induced by 5-HTP supplementation,
despite unchanged plasma serotonin levels, and the increased
concentration of serotonin in the cells of the gut affects
the secretion of gastric hormones as well as the delay of
gastric emptying induced by the fatty acids. The second
interpretation seemsmore likely butwould need independent
validation in future studies.
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